Navigation Links
Express Scripts Named one of Fortune Magazine's World's Most Admired Companies of 2017

ST. LOUIS, Feb. 16, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) was recognized today by Fortune Magazine as one of the World's Most Admired Companies within the Health Care: Pharmacy and Other Services category.

"Express Scripts is honored to be named one of the World's Most Admired Companies," said Tim Wentworth, CEO and President, Express Scripts. "This recognition is driven by the commitment and passion of our 26,000 employees to make medicine more affordable and accessible for the 85 million people we serve."

In partnership with the Hay Group, Fortune's World's Most Admired Companies list is based on surveys from 680 companies across 28 countries. To establish the rankings, company executives, board directors and outside analysts were asked to rate companies on nine criteria, including innovation, social responsibility and quality of products and services.

About Express Scripts Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit or follow @ExpressScripts on Twitter.

Media Contact: Ellen Drazen, Express Scripts 314-684-5355

To view the original version on PR Newswire, visit:

SOURCE Express Scripts
Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. Express Scripts Holding Company to Present at the Barclays Global Healthcare Conference
2. Express Scripts Announces a Tender Offer for Any and All of the Outstanding 3.125% Senior Notes due 2016
3. Gene Expression Analysis Market Worth 5.30 Billion USD by 2020
4. Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference
5. Express Scripts Holding Company Announces 2016 Financial Guidance Webcast And Conference Call
6. Express Scripts Champions $1 per Pill Access to an Alternative for Daraprim
7. Premera Blue Cross and Express Scripts Agree to Contract Extension
8. Perrigo Shareholders Convincingly Reject Mylans Tender Offer, Expressing Confidence in Perrigos Long-Term Strategy
9. Linden Care Corrects Express Scripts Allegations
10. Express Scripts to Present at the Credit Suisse Healthcare Conference
11. Express Scripts Announces 3rd Quarter Results; Increases 2015 Guidance Range
Post Your Comments:
(Date:10/11/2017)... Oct. 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... facility in Las Piedras, Puerto Rico ... blades. Following ... facility sustained minor structural damage, temporary loss of power ... have been completed, manufacturing operations have resumed, and the ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... at the University of California Berkeley, and other leading institutions in announcing the ... power of institutions to change the way animals are raised for food. , ...
Breaking Medicine News(10 mins):